Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-11-29

FDA Approved: DEXMETHYLPHENIDATE HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

The FDA approved Sun Pharmaceutical's supplemental application to market a generic dexmethylphenidate hydrochloride product for attention-deficit/hyperactivity …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexmethylphenidate hydrochloride (generic) (dexmethylphenidate hydrochloride)

Snippet

SUPPL AP for DEXMETHYLPHENIDATE HYDROCHLORIDE (DEXMETHYLPHENIDATE HYDROCHLORIDE)